SEMENT
Rather than the finish line, Sinema said the injury landed her in the hospital. The 44-year-old lawmaker, an avid runner, posted a photo of herself on Monday sitting in a wheelchair while wearing a white cast on her leg and holding crutches.
She expressed a desire to get back on her feet, writing, "I can't wait to help up and run [the Boston Marathon] with these speedy kids!"
https://thehill.com/blogs/in-the-know/in-the-know/558359-sinema-breaks-her-foot-running-marathon
Lateral Flow Testing for Workplaces - Are They Safe?
The US Food and Drug Agency has called into question the safety and efficacy of rapid lateral flow COVID-19 tests.
These rapid tests form the basis of the UK’s coronavirus testing programme, and have been recommended to help detect COVID-19 in people who are not showing symptoms.
According to an article published in the British Medical Journal, on 10 June 2021 The US Food and Drug Agency (FDA) warned the public to stop using the Innova SARS-CoV-2 antigen rapid qualitative test, suggesting they should be destroyed and binned.
An investigation carried out between March and April uncovered “significant concerns that the performance of the test has not been adequately established, presenting a risk to health.”
In addition, the FDA said that “labelling distributed with certain configurations of the test includes performance claims that did not accurately reflect the performance estimates observed during clinical studies,” and that the test “has not been authorised, cleared, or approved by the FDA for commercial distribution or use in the US, as required by law.”
Workplace Testing Programme
In February 2021, The Department of Health and Social Care started to work with key workplaces to ensure rapid testing was set up. Twelve UK organisations across almost 500 sites joined the government-backed rapid testing programme.
Lateral flow tests are now offered to everyone in England, with the government advising everyone to complete a test twice a week.
The idea behind the programme was that around one in three people who have coronavirus (COVID-19) have no symptoms and may be unknowingly spreading the virus. Testing will find more positive cases, keeping workers who cannot work from home unknowingly passing on the virus and protecting vital public services.
Some workplaces are also starting to keep records on employee vaccination status, including JP Morgan and Goldman Sachs. Staff at JP Morgan who have had two vaccine doses will reportedly not be required to wear face masks at work.
Moar…
https://www.twinfm.com/article/lateral-flow-testing-for-workplaces-are-they-safe
Covid-19: US regulator raises “significant concerns” over safety of rapid lateral flow tests
The US Food and Drug Agency (FDA) has raised concerns about the safety and the marketing of rapid lateral flow covid-19 tests, which are the cornerstone of the UK’s mass testing programme.
On 10 June,1 the agency warned the public to stop using the Innova SARS-CoV-2 antigen rapid qualitative test for detecting infection and suggested the tests should be destroyed and binned or returned to the manufacturer.
The FDA published a class 1 recall of the test after an investigation carried out between March and April uncovered “significant concerns that the performance of the test has not been adequately established, presenting a risk to health.” Class 1 is the most serious kind of recall and indicates that use of the tests may cause serious injury or death.
In addition, the FDA said that “labelling distributed with certain configurations of the test includes performance claims that did not accurately reflect the performance estimates observed during clinical studies,” and that the test “has not been authorised, cleared, or approved by the FDA for commercial distribution or use in the US, as required by law.”
moar…
https://www.bmj.com/content/373/bmj.n1514